Literature DB >> 26921622

A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept.

Carlo Alviggi1, Claus Y Andersen2, Klaus Buehler3, Alessandro Conforti1, Giuseppe De Placido1, Sandro C Esteves4, Robert Fischer5, Daniela Galliano6, Nikolaos P Polyzos7, Sesh K Sunkara8, Filippo M Ubaldi9, Peter Humaidan10.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26921622     DOI： 10.1016/j.fertnstert.2016.02.005

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  103 in total

1.  A novel mathematical model of true ovarian reserve assessment based on predicted probability of poor ovarian response: a retrospective cohort study.

Authors:  Huiyu Xu; Guoshuang Feng; Haiyan Wang; Yong Han; Rui Yang; Ying Song; Lixue Chen; Li Shi; Meng Qian Zhang; Rong Li; Jie Qiao
Journal:  J Assist Reprod Genet       Date:  2020-04-21       Impact factor: 3.412

Review 2.  Efficacy of the delayed start antagonist protocol for controlled ovarian stimulation in Bologna poor ovarian responders: a systematic review and meta-analysis.

Authors:  Shuang Yang; Nenghui Liu; Yanping Li; Lei Zhang; Rongya Yue
Journal:  Arch Gynecol Obstet       Date:  2020-11-24       Impact factor: 2.344

3.  Freeze-all cycle for all normal responders?

Authors:  Matheus Roque; Marcello Valle; Fernando Guimarães; Marcos Sampaio; Selmo Geber
Journal:  J Assist Reprod Genet       Date:  2016-11-05       Impact factor: 3.412

4.  Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A.

Authors:  Alberto Vaiarelli; Danilo Cimadomo; Gianluca Gennarelli; Maurizio Guido; Carlo Alviggi; Alessandro Conforti; Claudia Livi; Alberto Revelli; Silvia Colamaria; Cindy Argento; Maddalena Giuliani; Carlo De Angelis; Maria Matteo; Stefano Canosa; Angela D'Alfonso; Valentino Cimadomo; Laura Rienzi; Filippo Maria Ubaldi
Journal:  J Assist Reprod Genet       Date:  2022-02-07       Impact factor: 3.412

5.  Expression of pro-apoptotic and anti-apoptotic proteins in granulosa cells of women with diminished ovarian reserve.

Authors:  Sibel Bulgurcuoglu Kuran; Ayse Altun; Burcin Karamustafaoglu Balci; Ilknur Keskin; Meryem Hocaoglu
Journal:  J Assist Reprod Genet       Date:  2022-02-10       Impact factor: 3.412

6.  Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders.

Authors:  Min Xia; Jie Zheng
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-11       Impact factor: 3.007

7.  Reduced FSH and LH action: implications for medically assisted reproduction.

Authors:  E Bosch; C Alviggi; M Lispi; A Conforti; A C Hanyaloglu; D Chuderland; M Simoni; N Raine-Fenning; P Crépieux; S Kol; V Rochira; T D'Hooghe; P Humaidan
Journal:  Hum Reprod       Date:  2021-05-17       Impact factor: 6.918

8.  Beyond Premature Ovarian Insufficiency: Staging Reproductive Aging in Adolescent and Young Adult Cancer Survivors.

Authors:  Alexa C O Medica; Brian W Whitcomb; Ksenya Shliakhsitsava; Andrew C Dietz; Kelsey Pinson; Christina Lam; Sally A D Romero; Patrick Sluss; Mary D Sammel; H Irene Su
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

Review 9.  The Role of Androgen Supplementation in Women With Diminished Ovarian Reserve: Time to Randomize, Not Meta-Analyze.

Authors:  Ana Raquel Neves; Pedro Montoya-Botero; Nikolaos P Polyzos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555

10.  Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus.

Authors:  Raoul Orvieto; Christos A Venetis; Human M Fatemi; Thomas D'Hooghe; Robert Fischer; Yulia Koloda; Marcos Horton; Michael Grynberg; Salvatore Longobardi; Sandro C Esteves; Sesh K Sunkara; Yuan Li; Carlo Alviggi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-10       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.